Extract:
“National estimates of central line-associated bloodstream infections (CLABSI) are likely underestimated because only those that occur more than 72 hours after admission to an acute care hospital are routinely reported to the Centers for Disease Control and Prevention’s (CDC) National Healthcare Safety Network (NHSN). However, central lines (CLs) are increasingly used outside of acute care hospitals, in locations such as the patient home, outpatient infusion or chemotherapy centers, skilled nursing or long-term care facilities, home-based or facility-based dialysis centers, and rehabilitation facilities. CLABSIs that arise in these settings are not included in surveillance or reported systematically. Furthermore, patients often transition between patient homes, outpatient infusion centers, chemotherapy centers, skilled nursing or long-term care facilities, dialysis centers, rehabilitation facilities, and acute care hospitals (Figure 1), making it difficult to standardize infection tracking and reporting.”
Reference:Oladapo-Shittu O, Cosgrove SE, Rock C, Hsu YJ, Klein E, Harris AD, Mejia Chew C, Saunders H, Ching PR, Gadala A, Mayoryk S, Pineles L, Maragakis LL, Salinas AB, Helsel T, Keller SC; Centers for Disease Control and Prevention’s Prevention Epicenters Program. CLABSIs aren’t just for inpatients: the need to identify CLABSI burden among outpatients. Antimicrob Steward Healthc Epidemiol. 2024 Sep 12;4(1):e132. doi: 10.1017/ash.2024.384. PMID: 39290627; PMCID: PMC11406563.